TY - JOUR T1 - Endocannabinoid Signaling Mediates Psychomotor Activation by Adenosine A<sub>2A</sub> Antagonists JF - The Journal of Neuroscience JO - J. Neurosci. SP - 2160 LP - 2164 DO - 10.1523/JNEUROSCI.5844-09.2010 VL - 30 IS - 6 AU - Talia N. Lerner AU - Eric A. Horne AU - Nephi Stella AU - Anatol C. Kreitzer Y1 - 2010/02/10 UR - http://www.jneurosci.org/content/30/6/2160.abstract N2 - Adenosine A2A receptor antagonists are psychomotor stimulants that also hold therapeutic promise for movement disorders. However, the molecular mechanisms underlying their stimulant properties are not well understood. Here, we show that the robust increase in locomotor activity induced by an A2A antagonist in vivo is greatly attenuated by antagonizing cannabinoid CB1 receptor signaling or by administration to CB1−/− mice. To determine the locus of increased endocannabinoid signaling, we measured the amount of anandamide [AEA (N-arachidonoylethanolamine)] and 2-arachidonoylglycerol (2-AG) in brain tissue from striatum and cortex. We find that 2-AG is selectively increased in striatum after acute blockade of A2A receptors, which are highly expressed by striatal indirect-pathway medium spiny neurons (MSNs). Using targeted whole-cell recordings from direct- and indirect-pathway MSNs, we demonstrate that A2A receptor antagonists potentiate 2-AG release and induction of long-term depression at indirect-pathway MSNs, but not direct-pathway MSNs. Together, these data outline a molecular mechanism by which A2A antagonists reduce excitatory synaptic drive on the indirect pathway through CB1 receptor signaling, thus leading to increased psychomotor activation. ER -